Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes.

MLA

Izumi, Kouji, et al. “Tranilast Inhibits Hormone Refractory Prostate Cancer Cell Proliferation and Suppresses Transforming Growth Factor Β1-Associated Osteoblastic Changes.” Prostate, vol. 69, no. 11, Aug. 2009, pp. 1222–34. EBSCOhost, https://doi.org/10.1002/pros.20975.

APA

Izumi, K., Mizokami, A., Li, Y. Q., Narimoto, K., Sugimoto, K., Kadono, Y., Kitagawa, Y., Konaka, H., Koh, E., Keller, E. T., & Namiki, M. (2009). Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes. Prostate, 69(11), 1222–1234. https://doi.org/10.1002/pros.20975

Chicago

Izumi, Kouji, Atsushi Mizokami, You Qiang Li, Kazutaka Narimoto, Kazuhiro Sugimoto, Yoshifumi Kadono, Yasuhide Kitagawa, et al. 2009. “Tranilast Inhibits Hormone Refractory Prostate Cancer Cell Proliferation and Suppresses Transforming Growth Factor Β1-Associated Osteoblastic Changes.” Prostate 69 (11): 1222–34. doi:10.1002/pros.20975.